Life Science News

RSS

Penn researchers develop ApexGO to enhance promising antibiotic candidates

Researchers at the University of Pennsylvania have developed ApexGO, a novel, AI-powered method for turning promising but imperfect antibiotic candidates into more potent ones.

13 May 2026

Tracking the aging process across tens of millions of individual cells

While much is mysterious about the aging process, change over time remains its cornerstone. The biological shifts that accompany aging seemingly occur in many cells in the body.

13 May 2026

Researchers find new way to deliver drugs directly into cancer cells

National University of Singapore Researchers at the National University of Singapore (NUS) have developed a high-throughput method to identify gold nanoparticles capable of delivering therapies directly to mitochondria (the energy centres inside cancer cells).

13 May 2026

Scientists develop advanced lab-grown kidney organoids for disease research

A team led by USC Stem Cell scientist Zhongwei Li, PhD, has produced some of the most complex and mature lab-grown kidney models to date.

12 May 2026

Researchers uncover nuclear organization mechanism linked to Friedreich's ataxia

Researchers have uncovered a fundamental rule that governs how genes are physically arranged inside the cell nucleus, and how disruptions to that organization can contribute to human disease.

12 May 2026

Dual-pathway protein degradation approach could improve cancer treatment

Targeted protein degradation has become one of the most promising strategies in modern drug discovery, enabling scientists to eliminate disease-causing proteins instead of merely blocking them.

12 May 2026

Cedars-Sinai develops AI tool for faster and cheaper tumor analysis

A team led by Cedars-Sinai Health Sciences University investigators has created a faster, cheaper way to determine the genes expressed in cancerous tumors.

12 May 2026

KIT researchers develop contact-free laser technique to rotate microscopic samples

Until now, it has been technically nearly impossible to rotate highly sensitive samples in all directions under a microscope without making contact.

12 May 2026

Enterprise Therapeutics achieves primary efficacy outcome in Phase 2 clinical trial for cystic fibrosis with novel inhaled ENaC blocker ETD001

Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of people with respiratory diseases, today announced that its Phase 2 trial for ETD001, the Company's lead candidate for treatment of cystic fibrosis (CF), achieved its primary efficacy outcome.

From Enterprise Therapeutics Ltd 12 May 2026

Two proteins help maintain stem cells by preventing differentiation

Researchers from The University of Osaka find that the zinc finger proteins RLF and ZFP292 assist in stabilizing the CoREST corepressor complex at gene promoters in embryonic stem cells, preventing differentiation.

12 May 2026

BGI Genomics joins HGP2 Rare Disease Alliance to close rare disease care gap in Asia-Pacific

The HGP2 RaDiAnce-APAC initiative enhances rare disease diagnosis and genomic medicine, fostering collaboration for improved health in the Asia-Pacific region.

From BGI Genomics 12 May 2026

INDIGO Biosciences expands reporter assay capabilities with new Transrepression Assay Services

INDIGO Biosciences today announced the launch of its Transrepression Assay Services, expanding the company’s cell-based reporter assay capabilities for drug discovery teams studying pathway cross-talk, selective modulation, and transcription factor-mediated gene suppression.

From INDIGO Biosciences, Inc. 11 May 2026

Scientists call for explainable AI in protein language models

Protein language models are artificial intelligence tools which help engineer proteins with useful properties, including completely new structures never seen before in nature.

11 May 2026

Molecular switch in mice links energy burning and bone health

Scientists' discovery of a molecular "switch" that activates an energy‑burning pathway in mice has the potential to lead to new treatments for bone disease.

11 May 2026

Yale study finds garlic acts as birth control for mosquitoes

Garlic is not a substance that most people consider an aphrodisiac. It turns out that mosquitoes agree.

11 May 2026

New AI framework predicts how cells make fate decisions

Scientists at the Stowers Institute for Medical Research, Helmholtz Munich, the Technical University of Munich, and the University of Oxford have developed RegVelo - a new AI framework that simultaneously models cellular dynamics and gene regulation, enabling researchers to predict, simulate, and experimentally validate how cells make fate decisions.

11 May 2026

New CRISPR RNA scissors specifically target and destroy hepatitis E virus

An enzymatic scissors recognizes and cuts viral RNA, but leaves the host cell unharmed. This opens up new antiviral strategies against hepatitis E.

11 May 2026

FUJIFILM Biosciences and NextCell launch new commercial platform comprised of RUO stromal cells and cell culture media

FUJIFILM Biosciences, a global leader in the life science market, and NextCell Pharma AB, a clinical-stage company specializing in cell therapy using umbilical cord mesenchymal stromal cells (MSC), today announced a global commercial launch resulting from their strategic collaboration.

From FUJIFILM Biosciences 11 May 2026

Hovione and IDC Intranasal Drug Delivery Platform available for commercial partnerships

Hovione, a global integrated specialist CDMO, and Industrial Design Consultancy Ltd (IDC), an international product development company, today announced that their Intranasal Drug Delivery Platform has reached a new milestone, with its lead single-use nasal dry powder device now available for commercial partnerships.

From Hovione 11 May 2026

Uncountable expands specialty chemicals footprint with four new deals

Uncountable, a software company that develops AI platforms for end-to-end product development, today announced it has signed four new agreements with specialty chemicals organizations to support formulation development, scale-up, and production optimization.

From Uncountable Inc. 11 May 2026